|
|
||||||||
Columbia University College of Physicians and Surgeons, New York, New York
Accepted for publication August 20, 2009.
* Address correspondence to Dr Argenziano, Columbia University College of Physicians and Surgeons, 177 Fort Washington Ave, Milstein Hospital, Suite 7-435, New York, NY 10032 (Email: ma66{at}columbia.edu).
Presented at the Forty-fourth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 28–30, 2008.
Background: Percutaneous mitral repair with the MitraClip device (Evalve, Menlo Park, CA) has been reported. Preserving conventional surgical options in the event of percutaneous treatment failure is important. We describe surgical treatment at varying intervals after the MitraClip procedure in 32 patients.
Methods: One hundred seven patients with moderate-to-severe or severe mitral regurgitation who were either symptomatic (91%) or, if asymptomatic (9%), had evidence of left ventricular dysfunction were enrolled as part of the Endovascular Valve Edge-to-Edge REpair STudy (EVEREST) phase I registry study or as "roll-in" subjects in the EVEREST II study. Thirty-two of the 107 patients (30%) underwent surgery after an attempted MitraClip procedure.
Results: Of the 32 patients undergoing post-clip mitral valve surgery, 23 patients (72%) had one or more clips implanted and 9 patients (28%) received no clip implant. The indications for mitral valve surgery in the 23 patients with a clip included partial clip detachment (n = 10), residual or recurrent mitral regurgitation greater than 2+ (n = 9), and other (atrial septal defect [n = 2], device malfunction [n = 1], and incorrectly diagnosed mitral stenosis [n = 1]). Twenty-seven of 31 patients (87%) underwent the surgical procedure planned before surgery (planned procedure unknown in 1 patient). Four of 25 patients (16%) with planned repair underwent mitral valve replacement.
Conclusions: Standard surgical options were preserved in patients who had surgery after percutaneous repair with the MitraClip device. Successful repair was feasible in the majority of patients after the MitraClip procedure, with repair performed as late as 18 months after clip implantation.
This article has been cited by other articles:
![]() |
L. Conradi, H. Treede, O. Franzen, M. Seiffert, S. Baldus, J. Schirmer, T. Meinertz, and H. Reichenspurner Impact of MitraClip™ therapy on secondary mitral valve surgery in patients at high surgical risk Eur J Cardiothorac Surg, December 1, 2011; 40(6): 1521 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Maisano, G. La Canna, A. Colombo, and O. Alfieri The Evolution From Surgery to Percutaneous Mitral Valve Interventions: The Role of the Edge-to-Edge Technique. J. Am. Coll. Cardiol., November 15, 2011; 58(21): 2174 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Rogers and O. Franzen Percutaneous edge-to-edge MitraClip therapy in the management of mitral regurgitation Eur. Heart J., October 1, 2011; 32(19): 2350 - 2357. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Alfieri and P. Denti Alfieri stitch and its impact on mitral clip Eur J Cardiothorac Surg, June 1, 2011; 39(6): 807 - 808. [Full Text] [PDF] |
||||
![]() |
P. T. L. Chiam and C. E. Ruiz Percutaneous Transcatheter Mitral Valve Repair: A Classification of the Technology J. Am. Coll. Cardiol. Intv., January 1, 2011; 4(1): 1 - 13. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |